Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,090 | -40,270 | -100,625 | 21,796 | 17,214 |
| Depreciation Amortization | 4,121 | 5,199 | 6,132 | 5,642 | 4,495 |
| Accounts receivable | -5,960 | 306 | 682 | -772 | -729 |
| Accounts payable and accrued liabilities | -3,419 | 2,017 | 1,270 | -3,329 | 624 |
| Other Working Capital | -7,391 | -138 | -1,670 | -6,437 | -4,592 |
| Other Operating Activity | 41,968 | 42,136 | 104,439 | -3,744 | -953 |
| Operating Cash Flow | $7,229 | $9,250 | $10,228 | $13,156 | $16,059 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,528 | -4,839 | -4,215 | -7,094 | -8,270 |
| Purchase Sale Intangibles | -9,863 | -10,229 | -16,548 | -19,492 | -19,486 |
| Other Investing Activity | -9,863 | -11,341 | -17,660 | -20,604 | -19,486 |
| Investing Cash Flow | $-17,391 | $-16,180 | $-21,875 | $-27,698 | $-27,756 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 115,000 | N/A |
| Common Stock Issued | N/A | N/A | 857 | 2,943 | 3,642 |
| Common Stock Repurchased | -434 | -7,799 | -9,322 | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | -5,099 | -5,029 |
| Other Financing Activity | -16,438 | -4,844 | -4,890 | -5,324 | -40 |
| Financing Cash Flow | $-16,872 | $-12,643 | $-13,355 | $107,520 | $-1,427 |
| Exchange Rate Effect | -296 | 71 | 158 | -127 | -91 |
| Beginning Cash Position | 57,607 | 77,109 | 101,953 | 9,102 | 22,317 |
| End Cash Position | 30,277 | 57,607 | 77,109 | 101,953 | 9,102 |
| Net Cash Flow | $-27,330 | $-19,502 | $-24,844 | $92,851 | $-13,215 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,229 | 9,250 | 10,228 | 13,156 | 16,059 |
| Capital Expenditure | -7,528 | -4,839 | -4,215 | -7,094 | -8,270 |
| Free Cash Flow | -299 | 4,411 | 6,013 | 6,062 | 7,789 |